Non-Hodgkin Lymphoma (NHL)in India

Non-Hodgkin Lymphoma is a diverse group of blood cancers affecting lymphocytes, often treatable with targeted therapy or chemotherapy.

Top Oncology hospitals
Experienced Oncology surgeons
Support for international patients
Non-Hodgkin Lymphoma (NHL)
Dr. Mohammad Shavez
Written by:Mr. Mohd Ahsan
Medically Reviewed by:Dr. Mohammad Shavez
Updated At7 Oct 2026

Overview

Non-Hodgkin Lymphoma (NHL) represents a large group of blood cancers originating from lymphocytes.

It can appear in lymph nodes or other organs like the spleen and bone marrow.

New biologic and immunotherapies have improved survival across subtypes.

Overview And Clinical Background

NHL includes indolent and aggressive types based on how fast the cells grow.

The disease disrupts the immune system and blood cell production.

  • Origin:: From B-cells, T-cells, or NK-cells in the lymphatic system.
  • Types:: Includes diffuse large B-cell and follicular lymphoma.
  • Progression:: Can spread to bone marrow and organs.

Symptoms, Signs And Presentation

Symptoms depend on the site involved.

General symptoms like fever and weight loss are common.

  • Swollen lymph nodes:: Usually painless lumps in neck, armpit, or groin.
  • Fever and sweats:: B symptoms indicate systemic involvement.
  • Fatigue:: Due to anemia or immune suppression.

Diagnosis Methods And Investigations

Imaging And Laboratory Tests

Biopsy confirms diagnosis, while PET-CT determines disease stage and response.

  • Lymph node biopsy:: Essential for subtype identification.
  • PET-CT scan:: Maps disease spread and treatment response.
  • Bone marrow test:: Assesses marrow involvement.

Treatment Options And Surgical Techniques

Treatment varies with subtype and stage.

Most respond well to combined chemoimmunotherapy.

  • Chemotherapy (CHOP):: Standard for aggressive lymphomas.
  • Targeted therapy:: Rituximab for B-cell lymphomas improves outcomes.
  • Stem cell transplant:: For relapsed or high-risk patients.

Recovery, Risks And Prognosis

Many patients achieve long-term remission.

Indolent forms may recur but are manageable for years.

Why Choose Us

CureU Healthcare provides hematology experts, access to advanced biologics, and precise staging for tailored lymphoma care.

Conclusion

With new therapies and early diagnosis, Non-Hodgkin Lymphoma has become one of the most treatable blood cancers.

Dr. Mohammad Shavez
Medically Reviewed by
Dr. Mohammad Shavez

B.U.M.S, M.D. (NAT) | Reg No. 9153 | Ex. Secretary & Treasurer, N.I.M.A.

Qualified healthcare professional in Unani and Naturopathic medicine with deep expertise in traditional healthcare systems, patient-centered clinical care, and medical content review.

Frequently Asked Questions About Non-Hodgkin Lymphoma (NHL)

Hospitals Offering Oncology

BLK-Max Super Speciality Hospital, New Delhi

BLK-Max Super Speciality Hospital, New Delhi

Rajendra Place, New Delhi
650+
Beds
350+
Doctors
Indraprastha Apollo Hospital, New Delhi

Indraprastha Apollo Hospital, New Delhi

Sarita Vihar, New Delhi
700+
Beds
300+
Doctors
Aakash Healthcare Super Speciality Hospital, New Delhi

Aakash Healthcare Super Speciality Hospital, New Delhi

Dwarka Sector 3, New Delhi
230+
Beds
200+
Doctors
Batra Hospital & Medical Research Centre, New Delhi

Batra Hospital & Medical Research Centre, New Delhi

Tughlakabad Institutional Area, New Delhi
500+
Beds
250+
Doctors
Pristyn Care Diyos Hospital, New Delhi

Pristyn Care Diyos Hospital, New Delhi

Safdarjung Enclave, New Delhi
26
Beds
20+
Doctors
Fortis Hospital, Shalimar Bagh, New Delhi

Fortis Hospital, Shalimar Bagh, New Delhi

Shalimar Bagh, New Delhi
375
Beds
Expert Team
Doctors
IBS Institute of Brain and Spine, New Delhi

IBS Institute of Brain and Spine, New Delhi

Lajpat Nagar III, New Delhi
50
Beds
Specialist Team
Doctors
Call Us
Chat now
How can I help you?
CureU Medical Advisor

CureU Medical Advisor

online
🔒 100% Private & Medically ConfidentialCureU AI Care